CUSI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 17.039
EU - Europa 14.555
AS - Asia 8.290
SA - Sud America 1.513
AF - Africa 567
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 20
Totale 42.018
Nazione #
US - Stati Uniti d'America 16.802
RU - Federazione Russa 3.003
GB - Regno Unito 2.708
CN - Cina 2.695
SG - Singapore 2.521
IT - Italia 2.109
IE - Irlanda 2.007
BR - Brasile 1.253
UA - Ucraina 978
SE - Svezia 954
VN - Vietnam 903
FR - Francia 863
DE - Germania 853
HK - Hong Kong 705
FI - Finlandia 498
KR - Corea 411
ZA - Sudafrica 299
IN - India 270
BD - Bangladesh 154
CA - Canada 128
TR - Turchia 113
ES - Italia 111
IQ - Iraq 92
NL - Olanda 91
PL - Polonia 89
AR - Argentina 78
NG - Nigeria 73
CI - Costa d'Avorio 65
PK - Pakistan 61
MX - Messico 57
BE - Belgio 54
JP - Giappone 54
AT - Austria 50
EC - Ecuador 49
ID - Indonesia 44
CZ - Repubblica Ceca 41
SA - Arabia Saudita 41
CO - Colombia 32
VE - Venezuela 30
KE - Kenya 27
UZ - Uzbekistan 26
MA - Marocco 25
AU - Australia 23
CL - Cile 23
PH - Filippine 20
EU - Europa 19
PE - Perù 19
AE - Emirati Arabi Uniti 16
JO - Giordania 16
LT - Lituania 16
EG - Egitto 15
TN - Tunisia 14
AL - Albania 13
DZ - Algeria 13
KZ - Kazakistan 13
IL - Israele 12
NP - Nepal 12
PT - Portogallo 12
PY - Paraguay 12
MY - Malesia 11
PA - Panama 11
RS - Serbia 11
UY - Uruguay 11
IM - Isola di Man 10
NZ - Nuova Zelanda 10
TH - Thailandia 10
CH - Svizzera 9
ET - Etiopia 9
GR - Grecia 9
IR - Iran 9
AZ - Azerbaigian 8
BG - Bulgaria 7
CR - Costa Rica 7
HU - Ungheria 7
LB - Libano 7
GE - Georgia 6
GH - Ghana 6
HN - Honduras 6
NO - Norvegia 6
PS - Palestinian Territory 6
SY - Repubblica araba siriana 6
AM - Armenia 5
BO - Bolivia 5
CY - Cipro 5
DO - Repubblica Dominicana 5
HR - Croazia 5
JM - Giamaica 5
MT - Malta 5
OM - Oman 5
QA - Qatar 5
RO - Romania 5
SC - Seychelles 5
DK - Danimarca 4
GT - Guatemala 4
KG - Kirghizistan 4
KW - Kuwait 4
LK - Sri Lanka 4
LU - Lussemburgo 4
LV - Lettonia 4
SN - Senegal 4
Totale 41.954
Città #
Southend 2.288
Dallas 1.989
Dublin 1.969
Fairfield 1.484
Singapore 1.464
Ashburn 1.282
Chandler 1.124
Moscow 856
Woodbridge 770
Jacksonville 769
Santa Clara 759
Beijing 657
Hong Kong 656
Seattle 638
San Jose 632
Wilmington 623
Houston 580
Cambridge 533
Hefei 508
Siena 505
Ann Arbor 498
Seoul 397
Princeton 338
Los Angeles 270
Ho Chi Minh City 268
Nanjing 268
Johannesburg 267
New York 253
Helsinki 242
Menlo Park 233
The Dalles 232
Milan 230
Lauterbourg 223
Hanoi 212
Munich 193
Council Bluffs 161
Boardman 132
São Paulo 122
Buffalo 117
San Mateo 115
Rome 109
Florence 103
Nanchang 97
San Diego 92
London 79
Orem 76
Fremont 74
Abuja 70
Shanghai 70
Frankfurt am Main 68
Redondo Beach 68
Dong Ket 67
Abidjan 65
Turku 62
Warsaw 61
Dearborn 57
Bengaluru 56
Málaga 56
Shenyang 54
Chicago 53
Hebei 52
Brussels 49
Tianjin 49
Izmir 47
Chennai 46
Montreal 46
Da Nang 45
Tokyo 45
Toronto 45
Rio de Janeiro 42
Lappeenranta 41
Atlanta 40
Changsha 38
Norwalk 38
San Francisco 38
Columbus 36
Guangzhou 36
Haiphong 36
Lancaster 34
Nuremberg 34
Düsseldorf 32
Jiaxing 32
Vienna 32
Kunming 31
Washington 30
Baghdad 29
Brooklyn 29
Phoenix 29
Stockholm 29
Venezia 29
Tashkent 26
Porto Alegre 25
Belo Horizonte 24
Jinan 24
Amsterdam 23
Dhaka 23
Manchester 23
Brasília 22
Poplar 22
Mumbai 21
Totale 27.666
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 395
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 379
Immune response analysis to Measles virus in subjects vaccinated with MMR vaccine and naturally infected subjects. 372
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 363
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 351
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 350
Valutazione di un test in chemiluminescenza per la diagnosi sierologica di Leishmaniosi Viscerale 346
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 335
ERITEMA NODOSO RECIDIVANTE E PERSISTENTE REPLICA DI EPSTEIN-BARR VIRUS 332
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. 324
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 322
Peripheral biomarkers' panel for severe COVID-19 patients 318
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 317
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. 304
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 297
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 291
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 286
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 286
HCMV infection in renal transplant recipients: a retrospective cohort study 281
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 280
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 274
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 273
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 272
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection 272
Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy [Sieroprevalenza dell’infezione da virus dell’epatite E (HEV) in donatori di sangue e pazienti trapiantati di rene: Uno studio retrospettivo dal centro Italia] 266
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 266
Peptidi epitopici immunogenici del CEA da utilizzare nella chemio-immunoterapia del carcinoma del colon-retto e della mammella. 263
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 258
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 257
Beyond the biological effect of a chemically characterized poplar propolis: Antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells 255
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 251
In vitro neuraminidase inhibitory effect and activity against influenza virus A H1N1 of herbal drugs used for common cold 251
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 250
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 250
Serial KL-6 measurements in COVID-19 patients 248
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 247
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 244
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 243
Dendritic cell-cediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro 243
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. 242
Testicular involvement during Toscana-virus infection: an unusual manifestation? 234
FIBRILLO-FLUTTER IN ASSENZA DI SEGNI DI MIOCARDITE IN CORSO DI INFEZIONE DA EBV 233
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers 233
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects 227
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 226
Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine 225
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 225
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus 224
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 224
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 224
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 221
A Poly-epitopic peptide vaccine against the thymidylate synthase (TS). A synergistic therapeutic combination with fluoropyrimidine-based-chemotherapy 219
SARS-CoV-2 in pleural fluid in a kidney transplant patient 219
Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy 218
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 217
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 217
Identification of a neutralizing epitope on tosv gn glycoprotein 215
Diagnostic tools for Toscana virus infection 214
Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis 213
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 212
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 212
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 211
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 208
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 207
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients 207
Compartimentalizzazione di HCMV: mancata appropiatezza della sola DNAemia nella diagnosi e nella terapia di una polmonite da HCMV post-trapianto polmonare 206
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 206
Virosoma dell'influenza immunoricostituito (IRIV) contenente il gene per CD40L come immunoprotettore tumorale CEA-specifico e usi immunogenici di esso. 204
Effetti della dieta sulla secrezione di calcitonina nel neonato [The effects of diet on the secretion of calcitonin in the newborn infant] 202
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 202
Chemo-immunotherapy of colo-rectal cancer: Drug induced antigen specific cell-mediated immune response in vitro and in cancer patients 199
A Mediterranean arbovirus: the Toscana virus 199
A Polyepitope DNA Vaccine Targeted to Her-2/ErbB-2 Elicits a Broad Range of Human and Murine CTL Effectors to Protect against Tumor Challenge 199
Infection prevention in endoscopy practice; comparative evaluation of reusable vs single use endoscopic valves 199
Synthetic peptides of rubella E1 glycoprotein for serological assays 198
Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile 197
Pathogenic mechanism of Helicobacter pylori: production of cytoxin 197
Detection of RSV Genome in Cerebrospinal Fluid of a Patient with Guillain Barrè Syndrome: A Case Report 196
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 196
Applications of Influenza Virosomes as a delivery system 195
Development of a mouse model for the study of Toscana virus pathogenesis 190
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 190
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector 190
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 190
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 188
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 184
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 184
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 184
Epidemiological and clinical study of viral respiratory tract infections in children from Italy 183
ACKNOWLEDGEMENT OF REVIEWERS 183
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 181
Infections in liver and lung transplant recipients: A national prospective cohort 178
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 177
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 177
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 177
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 177
Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them. 176
Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity 175
Comparative performance of a new sars-cov-2 rapid detection system 175
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 174
Totale 23.767
Categoria #
all - tutte 131.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.508


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021281 0 0 0 0 0 0 0 0 0 0 0 281
2021/20222.586 162 272 145 200 127 88 121 141 218 279 249 584
2022/20234.058 248 324 509 539 412 817 80 349 424 102 166 88
2023/20243.124 109 108 267 178 101 817 1.073 76 18 77 64 236
2024/20256.357 181 354 556 342 713 354 306 376 554 280 647 1.694
2025/202614.112 1.156 2.111 1.574 1.787 2.714 621 1.651 541 582 811 421 143
Totale 42.516